Durability of mRNA-1273 protection against symptomatic COVID-19 examined - Medical Xpress
6/13/2022 12:00:00 AM2 years 10 months ago
by Science X staff
by Science X staff
For individuals who receive two doses of mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, vaccine efficacy (VE) against symptomatic COVID-19 appears to peak at 120 days after the first dose, according to a research letter publis…
For individuals who receive two doses of mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, vaccine efficacy (VE) against symptomatic COVID-19 appears to peak at 120 days… [+2101 chars]
full article...